PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the se…

Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?

Albrecht Stenzinger, MD - Optimising the Molecular Profiling Journey for Patients With CCA: Applying Best Practices and Avoiding Pitfalls

Olivier Bonnot, MD, PhD - Acute Psychosis: When to Suspect Acute Hepatic Porphyria

Darren M. Brenner / Benoît Coffin - If I'd Known Then What I Know Now: Recognising My First AHP Patient

Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED

Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding

Marwan Fakih, MD - The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line

Marwan Fakih, MD - Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

Philip James Tozer, MBBS, MD(Res), FRCS - Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy

Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment

Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC

Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools

Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise

Geoffrey Ku, MD - Here's The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers

Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses

Tanios Bekaii-Saab, MD - Expert Perspectives on Treatment Sequencing in Advanced CRC: Keys to Reaching Later Lines of Therapy

Gerald Prager, MD - Don't Leave a Drug on the Table: Maximising Use and Benefits of Later-Line Treatments for Advanced Colorectal Cancer

David T. Rubin, MD, AGAF - What They Say and What They Think: Exploring Tools for Assessing Bowel Urgency in Patients with Ulcerative Colitis

Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter?

Bruno Sangro, MD, PhD - A New Era in the Management of Advanced HCC: Sequencing Therapies for the Second-Line and Beyond

Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can't Wait': The Impact and Clinical Assessment of Bowel Urgency

Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics

Advanced Therapy for CPF in Crohn's: Evaluating the Evidence for Stem Cell Therapy and More

Perspectives on the Management of CPF: Moving the Goalposts With Shared Decision-Making

How I Treat: Achieving Healing in CPF

Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics

‘B' Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B

Complex Cases of Comorbidities in Patients With HCV

"De-Stigmatising Viral Hepatitis: Overcoming the Impact of the Whispered Epidemics!"

Shining a Light on the Treatment of Primary Hyperoxaluria 1: Does the Evidence Improve Our Options?

Applying Revised Treatment Guidelines for Advanced Hepatocellular Carcinoma: Considerations in Real-Life Practice

"The Changing Landscape for SCAC: What Clinicians Need to Know Now"

Incretin Effect 101: Why We Need to Look Beyond GLP-1 in T2DM

The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal

Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies

Non-Oncotic Methods for Managing the Milieu of Decompensated Liver Cirrhosis

Acute Psychosis: When to Suspect Acute Hepatic Porphyria

Identifying Bowel Urgency in Patients With Ulcerative Colitis: The Need for Speed

If I'd Known Then What I Know Now: Recognising My First AHP Patient

Transforming the Treatment of Acute Hepatic Porphyria

The First Biologic in IBD: When, Which, and Why?

Proactive IBD Care: Identifying Patients at Risk of Disease Progression